Announcements Trials

Browse Landscape

Phase

Phase 2 8 Phase 1/2 5 Phase 3 4 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Paclitaxel 9 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Cisplatin 8 Carboplatin 8 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Radiotherapy, Intensity-Modulated 6 Nivolumab 6 Leucovorin 6 Filgrastim 6 Drug Therapy 6 Doxorubicin 6 Radiotherapy 5 Oxaliplatin 5 Fluorouracil 5 Docetaxel 5 Bevacizumab 5 pembrolizumab 4 gallium 68 PSMA-11 4 Taxes 4 Sirolimus 4 Rituximab 4 Pemetrexed 4 Melphalan 4 Immunoglobulin G 4 Gemcitabine 4 Disulfides 4 Dexamethasone 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Has results × Tiragolumab × Clear all

NCT04619797 2026-06-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed

542 enrolled 28 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡